SEC 13F Intelligence

Foresite Capital Management Vi LLC / CGEM

Foresite Capital Management Vi LLC’s Cullinan Therapeutics Inc Position

Does Foresite Capital Management Vi LLC own Cullinan Therapeutics Inc (CGEM)? Not currently — the last reported position was 594.0K shares worth $4M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q2 2025
Shares
594.0K
% of Portfolio
+2.51%
Quarters Held
3
position exited

Position History CGEM

Reported value by quarter
Q4 ’24: $8MQ4 ’24Q1 ’25: $5MQ1 ’25Q2 ’25: $4MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025594.0K$4M+2.51%
Q1 2025634.6K$5M+2.63%
Q4 2024634.6K$8M+3.44%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of CGEM.